A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
Clinical trial NCT07176702 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07176702
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-03-05
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.